Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

Share Price Information for Tyman (TYMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 360.50
Bid: 360.00
Ask: 361.00
Change: -0.50 (-0.14%)
Spread: 1.00 (0.278%)
Open: 361.00
High: 361.00
Low: 359.50
Prev. Close: 361.00
TYMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LTIP Awards and Directors' Dealing

13 Dec 2010 07:00

RNS Number : 7905X
Lupus Capital PLC
13 December 2010
 



 

 

Lupus Capital plc

 

LTIP Awards and Directors' Dealing

 

Lupus Capital plc ("Lupus" or the "Company"), a leading international supplier of building products to the door and window industry and the world's number one manufacturer of marine breakaway couplings, announces that on 10 December 2010, the Remuneration Committee of the Company granted the following nil cost share awards over ordinary shares of 5 pence each in the Company ("Ordinary Shares") to the Executive Directors of the Company under the Lupus Long Term Incentive Plan (the "LTIP").

 

Name

Number of Ordinary Shares subject to the LTIP Award

Louis Eperjesi

200,000

James Brotherton

150,000

 

A further 48 senior managers and executives employed by the Company and its subsidiaries will be granted nil or nominal cost share awards (depending on jurisdiction) over a total of 1,063,000 Ordinary Shares prior to the year end.

 

In aggregate, and according to the terms of the LTIP approved by shareholders on 30 November 2010, by the year end a total of 1,413,000 nil or nominal cost share awards will have been granted to 50 individuals.

 

All awards are subject to performance and other vesting criteria, as set out in the shareholder circular dated 10 November 2010, a copy of which is available on the Company's website - www.lupuscapital.co.uk.

 

Following the grant of these awards, the aforementioned Executive Directors have the following interests in the Company's share capital:

 

Ordinary Shares

LTIP Awards

Other Options

Name

Number

%

Number

%

Number

%

Louis Eperjesi

145,000

0.11

200,000

0.15

Nil

n/a

James Brotherton

149,141

0.11

150,000

0.12

100,000

0.08

 

All percentages are expressed as a percentage of the Company's current voting share capital being 129,840,798 Ordinary Shares.

 

Enquiries:

 

Lupus Capital plc

+44 (0)20 7976 8000

Jamie Pike (Chairman)

Les Tench (Chairman of Remuneration Committee)

Collins Stewart Europe Limited

+44 (0)20 7523 8350

Mark Dickenson / Tom Hulme

College Hill

+44 (0)20 7457 2020

Mark Garraway / Adam Aljewicz

 

13 December 2010

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSURSBRROAUAAA
Date   Source Headline
23rd Apr 20241:59 pmRNSForm 8.3 - Quanex Building Products Corporation
23rd Apr 20241:58 pmRNSForm 8.3 - Tyman plc
23rd Apr 20241:55 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tyman plc
23rd Apr 20241:22 pmRNSForm 8.3 - Tyman plc
23rd Apr 20241:14 pmEQSForm 8.3 - Apex Fundrock Limited : Re Tyman plc
23rd Apr 202412:48 pmGNWForm 8.3 - Tyman plc
23rd Apr 202412:22 pmRNSForm 8.3 - Tyman plc
23rd Apr 202412:10 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - TYMAN PLC - Ordinary Shares
23rd Apr 202412:09 pmGNWMan Group PLC : Form 8.3 - Tyman plc
23rd Apr 202411:57 amRNSForm 8.3 - Tyman Plc
23rd Apr 202411:53 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:45 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:41 amPRNForm 8.3 - Tyman plc
23rd Apr 202411:35 amRNSForm 8.5 (EPT/RI) - Tyman Plc
23rd Apr 202411:32 amRNSForm 8.3 -Quanex Building Products Corporation
23rd Apr 202411:29 amRNSForm 8.3 - Tyman plc
23rd Apr 202410:49 amRNSForm 8.5 (EPT/RI) - Tyman Plc
22nd Apr 20242:59 pmRNSForm 8.3 - Quanex Building Products Corporation
22nd Apr 20242:57 pmRNSForm 8.3 - Tyman plc
22nd Apr 202412:01 pmPRNForm 8.3 - Tyman plc
22nd Apr 20247:00 amRNSRecommended Cash and Share Offer
17th Apr 202411:22 amRNSHolding(s) in Company
28th Mar 20247:00 amRNS2023 Annual Report & Notice of AGM
7th Mar 20247:00 amRNSFinal Results
31st Jan 20247:00 amRNSNotice of Results
10th Jan 20248:00 amRNSDirector Declaration
27th Nov 20236:17 pmRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSAppointment of new CEO
20th Nov 20232:00 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Statement
31st Oct 20237:00 amRNSCapital Markets Event
2nd Oct 20237:00 amRNSNotice of Capital Markets Event
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20235:00 pmRNSAcquisition of Lawrence Industries
8th Jun 20239:21 amRNSHolding(s) in Company
1st Jun 20237:00 amRNSSBTi approval of carbon reduction targets
31st May 20237:00 amRNSDirectorate Changes
26th May 202310:59 amRNSDirector/PDMR Shareholding
19th May 202310:24 amRNSDirector/PDMR Shareholding
18th May 20231:30 pmRNSResult of AGM
18th May 20237:00 amRNSAGM Trading Update
21st Apr 20237:00 amRNSAppointment of Interim Chief Financial Officer
21st Apr 20237:00 amRNSDirector/PDMR Shareholding
6th Apr 20233:10 pmRNSAGM Update - Withdrawal of AGM Resolution
6th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20239:10 amRNSDirector/PDMR Shareholding
24th Mar 20231:34 pmRNSHolding(s) in Company
22nd Mar 20234:30 pmRNSDirector/PDMR Shareholding
14th Mar 20234:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.